Eleftherios Michailidis

15.1k total citations · 3 hit papers
46 papers, 2.1k citations indexed

About

Eleftherios Michailidis is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Eleftherios Michailidis has authored 46 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Infectious Diseases, 17 papers in Virology and 17 papers in Epidemiology. Recurrent topics in Eleftherios Michailidis's work include HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (17 papers) and Hepatitis B Virus Studies (12 papers). Eleftherios Michailidis is often cited by papers focused on HIV/AIDS drug development and treatment (19 papers), HIV Research and Treatment (17 papers) and Hepatitis B Virus Studies (12 papers). Eleftherios Michailidis collaborates with scholars based in United States, Japan and Greece. Eleftherios Michailidis's co-authors include Charles M. Rice, Stefan G. Sarafianos, Karen A. Kirby, Michael A. Parniak, Bruno Marchand, Kamalendra Singh, Hans-Heinrich Hoffmann, William M. Schneider, Amir Shlomai and Eiichi Kodama and has published in prestigious journals such as Nature, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Eleftherios Michailidis

41 papers receiving 2.1k citations

Hit Papers

Enhanced SARS-CoV-2 neutralization by dimeric IgA 2015 2026 2018 2022 2020 2015 2020 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Enhanced SARS-CoV-2 neutralization by dimeric IgA
    2020 294 citations Hans-Heinrich Hoffmann, Eleftherios Michailidis et al. profile →
  2. CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus
    2015 244 citations Vyas Ramanan, Amir Shlomai et al. profile →
  3. Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks
    2020 243 citations William M. Schneider, Joseph M. Luna et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Eleftherios Michailidis United States 24 1.2k 726 691 531 388 46 2.1k
Jérôme Deval United States 27 1.3k 1.1× 628 0.9× 510 0.7× 490 0.9× 222 0.6× 46 2.0k
Nir Paran Israel 24 772 0.7× 768 1.1× 962 1.4× 659 1.2× 117 0.3× 58 2.0k
Klaus Korn Germany 30 1.3k 1.1× 693 1.0× 418 0.6× 818 1.5× 178 0.5× 107 2.4k
Robert L. LaFemina United States 20 976 0.8× 1.1k 1.5× 972 1.4× 782 1.5× 395 1.0× 27 2.2k
Jian Yu United States 29 2.6k 2.2× 488 0.7× 979 1.4× 442 0.8× 202 0.5× 60 3.8k
Sam Hopkins United States 18 682 0.6× 354 0.5× 741 1.1× 735 1.4× 274 0.7× 25 1.7k
Udayan Chatterji United States 28 372 0.3× 789 1.1× 855 1.2× 769 1.4× 642 1.7× 51 2.0k
Michael M. Thomson Spain 34 1.6k 1.4× 849 1.2× 497 0.7× 1.9k 3.6× 427 1.1× 88 2.9k
Yasumasa Iwatani Japan 26 1.3k 1.1× 608 0.8× 947 1.4× 1.3k 2.4× 111 0.3× 107 2.5k
Shirit Einav United States 28 696 0.6× 581 0.8× 749 1.1× 172 0.3× 474 1.2× 59 2.3k

Countries citing papers authored by Eleftherios Michailidis

Since Specialization
Citations

This map shows the geographic impact of Eleftherios Michailidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eleftherios Michailidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eleftherios Michailidis more than expected).

Fields of papers citing papers by Eleftherios Michailidis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eleftherios Michailidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eleftherios Michailidis. The network helps show where Eleftherios Michailidis may publish in the future.

Co-authorship network of co-authors of Eleftherios Michailidis

This figure shows the co-authorship network connecting the top 25 collaborators of Eleftherios Michailidis. A scholar is included among the top collaborators of Eleftherios Michailidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eleftherios Michailidis. Eleftherios Michailidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Upadhyay, Aditya, Mohammad Kabbani, Vijay Soni, et al.. (2025). Halting Hypercaloric Feeding in Liver Chimeric Mice Rapidly Resolves Human Hepatocyte Steatosis. Gastro Hep Advances. 4(10). 100758–100758.
2.
Jones, Christopher E., M. Glenn Koenig, Luiz C. A. Barbosa, et al.. (2024). Long-term 3D cell culture models for hepatitis B virus studies. Virology. 600. 110265–110265.
3.
Liu, Dandan, Andrew D. Huber, Eleftherios Michailidis, et al.. (2023). Mechanisms of Action of the Host-Targeting Agent Cyclosporin A and Direct-Acting Antiviral Agents against Hepatitis C Virus. Viruses. 15(4). 981–981. 1 indexed citations
4.
Amblard, Franck, Dharmeshkumar Patel, Eleftherios Michailidis, et al.. (2022). HIV nucleoside reverse transcriptase inhibitors. European Journal of Medicinal Chemistry. 240. 114554–114554. 31 indexed citations
5.
Hoffmann, Hans-Heinrich, Francisco J. Sánchez‐Rivera, William M. Schneider, et al.. (2020). Functional interrogation of a SARS-CoV-2 host protein interactome identifies unique and shared coronavirus host factors. Cell Host & Microbe. 29(2). 267–280.e5. 108 indexed citations
6.
Schneider, William M., Joseph M. Luna, Hans-Heinrich Hoffmann, et al.. (2020). Genome-Scale Identification of SARS-CoV-2 and Pan-coronavirus Host Factor Networks. Cell. 184(1). 120–132.e14. 243 indexed citations breakdown →
7.
Xiang, Kuanhui, Eleftherios Michailidis, Yao Li, et al.. (2016). Effects of amino acid substitutions in hepatitis B virus surface protein on virion secretion, antigenicity, HBsAg and viral DNA. Journal of Hepatology. 66(2). 288–296. 63 indexed citations
8.
Billerbeck, Eva, Michiel C. Mommersteeg, Amir Shlomai, et al.. (2016). Humanized mice efficiently engrafted with fetal hepatoblasts and syngeneic immune cells develop human monocytes and NK cells. Journal of Hepatology. 65(2). 334–343. 65 indexed citations
9.
Shlomai, Amir, Eleftherios Michailidis, Ankit Bhatta, et al.. (2015). CRISPR/Cas9 cleavage of viral DNA efficiently suppresses hepatitis B virus. Nature. 7 indexed citations
10.
Ricardo-Lax, Inna, Vyas Ramanan, Eleftherios Michailidis, et al.. (2015). Hepatitis B virus induces RNR-R2 expression via DNA damage response activation. Journal of Hepatology. 63(4). 789–796. 31 indexed citations
11.
Michailidis, Eleftherios, Emily Ryan, Atsuko Hachiya, et al.. (2013). Hypersusceptibility mechanism of Tenofovir-resistant HIV to EFdA. Retrovirology. 10(1). 65–65. 31 indexed citations
12.
Tavis, John E., Xiaohong Cheng, Yuan Hu, et al.. (2013). The Hepatitis B Virus Ribonuclease H Is Sensitive to Inhibitors of the Human Immunodeficiency Virus Ribonuclease H and Integrase Enzymes. PLoS Pathogens. 9(1). e1003125–e1003125. 92 indexed citations
13.
Singh, Kamalendra, Bruno Marchand, K. Devendra, et al.. (2012). Biochemical Mechanism of HIV-1 Resistance to Rilpivirine. Journal of Biological Chemistry. 287(45). 38110–38123. 55 indexed citations
14.
Hachiya, Atsuko, Bruno Marchand, Karen A. Kirby, et al.. (2012). HIV-1 Reverse Transcriptase (RT) Polymorphism 172K Suppresses the Effect of Clinically Relevant Drug Resistance Mutations to Both Nucleoside and Non-nucleoside RT Inhibitors. Journal of Biological Chemistry. 287(35). 29988–29999. 9 indexed citations
15.
Kirby, Karen A., Bruno Marchand, Yee Tsuey Ong, et al.. (2012). Structural and Inhibition Studies of the RNase H Function of Xenotropic Murine Leukemia Virus-Related Virus Reverse Transcriptase. Antimicrobial Agents and Chemotherapy. 56(4). 2048–2061. 26 indexed citations
16.
Michailidis, Eleftherios, Karen A. Kirby, Atsuko Hachiya, et al.. (2012). Antiviral therapies: Focus on hepatitis B reverse transcriptase. The International Journal of Biochemistry & Cell Biology. 44(7). 1060–1071. 38 indexed citations
17.
Kirby, Karen A., Kamalendra Singh, Eleftherios Michailidis, et al.. (2011). The sugar ring conformation of 4'-ethynyl-2-fluoro-2'-deoxyadenosine and its recognition by the polymerase active site of HIV reverse transcriptase.. PubMed. 57(1). 40–6. 21 indexed citations
18.
Hachiya, Atsuko, Eiichi Kodama, Karen A. Kirby, et al.. (2011). K70Q Adds High-Level Tenofovir Resistance to “Q151M Complex” HIV Reverse Transcriptase through the Enhanced Discrimination Mechanism. PLoS ONE. 6(1). e16242–e16242. 25 indexed citations
19.
Michailidis, Eleftherios, Bruno Marchand, Eiichi Kodama, et al.. (2009). Mechanism of Inhibition of HIV-1 Reverse Transcriptase by 4′-Ethynyl-2-fluoro-2′-deoxyadenosine Triphosphate, a Translocation-defective Reverse Transcriptase Inhibitor. Journal of Biological Chemistry. 284(51). 35681–35691. 112 indexed citations
20.
Liapis, Angelos, et al.. (2004). Mucinous tumors of the appendix presenting as primary tumors of the ovary. Report of two cases.. PubMed. 25(1). 113–5. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jérôme Deval Breakdown of academic impact, for papers by Nir Paran Breakdown of academic impact, for papers by Klaus Korn Breakdown of academic impact, for papers by Robert L. LaFemina Breakdown of academic impact, for papers by Jian Yu Breakdown of academic impact, for papers by Sam Hopkins Breakdown of academic impact, for papers by Udayan Chatterji Breakdown of academic impact, for papers by Michael M. Thomson Breakdown of academic impact, for papers by Yasumasa Iwatani Breakdown of academic impact, for papers by Shirit Einav
Rankless by CCL
2026